Vancouver, Wash. biotech company Absci files to go public

Absci CEO and founder Sean McClain. (Absci Photo)Absci, a Vancouver, Wash.-based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. The company’s platform is built to design and generate protein-based drug candidates and help screen them for optimal functioning. The announcement follows a string of acquisitions and funding…
« Previous post: | Next post: »